Try our Advanced Search for more refined results
June 14, 2013
Cataletto et al v. Amylin Pharmaceuticals, LLC et al
Case Number:
1:13-cv-03411
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 18, 2013
Merck, Bristol-Myers Sued Over Diabetes Drugs' Cancer Risks
Merck & Co. Inc., a Bristol-Myers Squibb Co. subsidiary and Eli Lilly & Co. were all targeted by a New York product liability suit Friday alleging they concealed a link between certain diabetes drugs currently under regulatory investigation and the risk for pancreatic cancer.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login